Results 161 to 170 of about 101,334 (310)

Pharmacokinetics, Pharmacodynamics, Efficacy and Drug Resistance Selection of Injectable Long‐Acting Lenacapavir Pre‐Exposure Prophylaxis (PrEP) Against HIV

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 5, May 2026.
ABSTRACT Oral pre‐exposure prophylaxis (PrEP) can substantially reduce HIV infection risk when taken as prescribed. However, many individuals struggle adhering to the daily regimen. Twice‐yearly injections of the novel HIV capsid inhibitor lenacapavir (LEN) demonstrated potential in recent PrEP trials.
Hee‐yeong Kim, Antonia Liebenberg, Lanxin Zhang, Max von Kleist   +3 more
wiley   +1 more source

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study. [PDF]

J Clin Med, 2023
Krysiak R, Kowalcze K, Okopień B.
europepmc   +1 more source

Biographical Discovery, Affirmation, and Disruption: Trans and Nonbinary Peoples' Experiences Negotiating Gender and Polycystic Ovary Syndrome

Sociology of Health &Illness, Volume 48, Issue 4, May 2026.
ABSTRACT Polycystic ovary syndrome (PCOS) is the most common endocrine irregularity in people who are assigned‐female‐at‐birth and are of reproductive age. PCOS causes infertility, irregular periods and hirsutism. Cis women with PCOS describe these symptoms as ‘masculinising,’ which makes them feel inauthentic as women.
Annie McGhee, Ashlyn Arthur
wiley   +1 more source

Birth and abortion rates among young women over the past 50 years examined in relation to providers and reimbursement for hormonal contraception across the Nordic countries, an ecological study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 847-858, May 2026.
Along with the liberalization of the abortion laws in the Nordic countries during the 1970s, there were efforts to prevent unplanned pregnancies among young women by improved contraceptive provisions. The strategies for preventing unplanned pregnancies have varied across the Nordic countries.
Finn Egil Skjeldestad, Mika Gissler, Reynir Tómas Geirsson, Kristina Gemzell‐Danielsson, Oskari Heikinheimo   +4 more
wiley   +1 more source

The Preoperative Management of Oral Contraceptive Pills in Aesthetic Plastic Surgery Practice in Saudi Arabia. [PDF]

Cureus, 2022
Aljindan F, Allababidi NH, Mortada H, Alhumaid F, Alzaidi SA.   +4 more
europepmc   +1 more source

Impact of combined oral contraceptives and progestin‐only pills on psychological and sexual well‐being of women with endometriosis: A systematic review

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 805-818, May 2026.
Hormonal treatments for endometriosis (combined oral contraceptives/progestin‐only pills) do not show increased psychological or sexual risks compared with placebo. When pain is effectively controlled, these therapies appear well tolerated and may improve overall well‐being.
Noemi Salmeri, Martina Piccini, Francesca Caprara, Edgardo Somigliana, Paola Viganò, Paolo Vercellini   +5 more
wiley   +1 more source

Condom use within marriage: a neglected HIV intervention

Bulletin of the World Health Organization, 2004
OBJECTIVE: To assess the contraceptive effectiveness of condoms versus oral contraceptive pills and estimate the reproductive consequences of a major shift from pill to condom use.
Ali Mohamed M., Cleland John, Shah Iqbal H.   +2 more
doaj  

Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's Disease. [PDF]

Crohns Colitis 360, 2022
Daoud ND, Ghoz H, Cannon R, Farraye JA, Picco MF, Kane SV, Kochhar GS, Woodhams EJ, Farraye FA.   +8 more
europepmc   +1 more source

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills. [PDF]

Cureus, 2022
Fattah A, Al-Kader DA, Jones Amaowei EE, Amini H, Hewadmal H, Rasuli SF, Ikedum IV, Farooq J, Bashar M, Qadar LT.   +9 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source